A
Aker Biomarine ASA
OSE:AKBM
Aker Biomarine ASA
OSE:AKBM
Price:
60.5
NOK
-2.89%
Market Closed
Market Cap:
5.3B
NOK
Balance Sheet
Balance Sheet Decomposition
Aker Biomarine ASA
Aker Biomarine ASA
| Current Assets | 166.3m |
| Cash & Short-Term Investments | 15m |
| Receivables | 55.1m |
| Other Current Assets | 96.2m |
| Non-Current Assets | 221.1m |
| Long-Term Investments | 400k |
| PP&E | 70.7m |
| Intangibles | 104.3m |
| Other Non-Current Assets | 45.7m |
Balance Sheet
Aker Biomarine ASA
Aker Biomarine ASA
Currency: USD
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
3
|
2
|
2
|
12
|
9
|
9
|
22
|
28
|
15
|
|
| Cash Equivalents |
2
|
3
|
2
|
2
|
12
|
9
|
9
|
22
|
28
|
15
|
|
| Total Receivables |
24
|
17
|
19
|
20
|
50
|
64
|
60
|
83
|
66
|
55
|
|
| Accounts Receivables |
13
|
17
|
19
|
20
|
37
|
54
|
50
|
0
|
58
|
0
|
|
| Other Receivables |
10
|
0
|
0
|
0
|
13
|
10
|
10
|
0
|
9
|
0
|
|
| Inventory |
36
|
39
|
36
|
44
|
95
|
115
|
138
|
183
|
184
|
96
|
|
| Other Current Assets |
7
|
10
|
16
|
16
|
25
|
35
|
32
|
11
|
8
|
0
|
|
| Total Current Assets |
68
|
68
|
73
|
81
|
183
|
223
|
240
|
299
|
283
|
166
|
|
| PP&E Net |
113
|
141
|
207
|
232
|
319
|
280
|
339
|
343
|
351
|
71
|
|
| PP&E Gross |
113
|
141
|
207
|
232
|
319
|
280
|
339
|
343
|
351
|
0
|
|
| Accumulated Depreciation |
63
|
67
|
73
|
83
|
107
|
128
|
165
|
166
|
195
|
0
|
|
| Intangible Assets |
5
|
3
|
30
|
48
|
96
|
86
|
77
|
68
|
61
|
104
|
|
| Goodwill |
65
|
65
|
65
|
66
|
95
|
95
|
95
|
95
|
95
|
0
|
|
| Note Receivable |
6
|
2
|
2
|
2
|
0
|
9
|
7
|
8
|
6
|
5
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
8
|
0
|
2
|
32
|
41
|
|
| Other Assets |
65
|
65
|
65
|
66
|
95
|
95
|
95
|
95
|
95
|
0
|
|
| Total Assets |
258
N/A
|
279
+8%
|
377
+35%
|
430
+14%
|
692
+61%
|
700
+1%
|
757
+8%
|
825
+9%
|
827
+0%
|
387
-53%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
5
|
7
|
11
|
11
|
23
|
20
|
25
|
57
|
94
|
43
|
|
| Accrued Liabilities |
8
|
11
|
13
|
11
|
26
|
15
|
18
|
0
|
31
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
14
|
29
|
13
|
17
|
0
|
15
|
0
|
|
| Current Portion of Long-Term Debt |
11
|
16
|
17
|
12
|
18
|
20
|
14
|
48
|
34
|
7
|
|
| Other Current Liabilities |
5
|
9
|
7
|
6
|
2
|
3
|
4
|
0
|
2
|
0
|
|
| Total Current Liabilities |
29
|
43
|
48
|
54
|
100
|
71
|
77
|
105
|
113
|
50
|
|
| Long-Term Debt |
147
|
156
|
258
|
179
|
372
|
211
|
294
|
334
|
344
|
140
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
5
|
5
|
8
|
4
|
8
|
|
| Other Liabilities |
6
|
7
|
12
|
18
|
66
|
41
|
11
|
0
|
0
|
15
|
|
| Total Liabilities |
182
N/A
|
205
+13%
|
318
+55%
|
251
-21%
|
538
+114%
|
327
-39%
|
387
+18%
|
446
+15%
|
461
+3%
|
214
-54%
|
|
| Equity | |||||||||||
| Common Stock |
64
|
64
|
64
|
68
|
68
|
76
|
76
|
76
|
76
|
0
|
|
| Retained Earnings |
144
|
146
|
161
|
167
|
191
|
196
|
204
|
194
|
203
|
0
|
|
| Additional Paid In Capital |
192
|
192
|
192
|
313
|
313
|
530
|
530
|
530
|
530
|
0
|
|
| Other Equity |
35
|
35
|
35
|
35
|
35
|
36
|
31
|
33
|
36
|
174
|
|
| Total Equity |
76
N/A
|
74
-3%
|
59
-20%
|
179
+202%
|
155
-14%
|
373
+141%
|
370
-1%
|
379
+2%
|
367
-3%
|
174
-53%
|
|
| Total Liabilities & Equity |
258
N/A
|
279
+8%
|
377
+35%
|
430
+14%
|
692
+61%
|
700
+1%
|
757
+8%
|
825
+9%
|
827
+0%
|
387
-53%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
88
|
88
|
88
|
88
|
88
|
88
|
88
|
88
|
88
|
88
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
